| randomised controlled trial of recombinant human interferon -alpha a for chronic active hepatitis b. | the efficacy of interferon treatment for australian patients with chronic active hepatitis b (cah-b) was assessed by a three-centre randomised controlled trial in sydney and brisbane. thirty patients (29 with histologically-proven cah-b with and without cirrhosis and one with chronic persistent hepatitis) were allocated to receive either thrice weekly intramuscular injections of recombinant human leucocyte interferon -alpha a (either 2.5, 5.0 or 10.0 million units/m2) for six months followed by ... | 1990 | 2181991 |